Fred Hutchinson Cancer Research Center is the third institution to gain an academic bridge program in collaboration with Evotec, with the latest instalment dubbed Lab591.

Two years after investing a reported $7m in the robo-advisor developer, Allianz Asset Management has returned to lead a $53.1m round.

The EMS-backed gene therapy developer has filed for an $86.3m offering having raised about the same amount in venture funding.

BridgeBio Pharma retains a majority stake in spinoff Eidos, which has raised $91m in funding in just over a year.

PayPal and Temasek have invested $125m in POS technology provider Pine Labs, less than three months after it raised money at a valuation of up to $900m.

Stealth-stage manufacturing technology startup Auto has reportedly secured $200m in funding in the 10 months since it was spun off from Flex.

The fraud protection software provider is valued at about $400m, following an American Express Ventures-backed round led by Premji Invest.

Myriad Genetics will pay $375m in cash and stock for genetic screening provider Counsyl, allowing Illumina Ventures to exit.

AI technology producer SenseTime has added series C+ funding to a $600m series C round it closed just last month, and is valued at $4.5bn.

InnovAllianz, an investment subsidiary of Allianz, has contributed to a $15m funding round for 3D organ printing company Biomodex.